• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594883)   Today's Articles (8)   Subscriber (49330)
Number Citation Analysis
26
Bourlond F, Battistella M, Amici JM, Dousset L, Vergier B, Beylot-Barry M, Cribier B. Clinicopathologic analysis of trichoblastoma and comparison with nodular basal cell carcinoma. Ann Dermatol Venereol 2021;148:177-182. [PMID: 34176642 DOI: 10.1016/j.annder.2021.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 12/15/2020] [Accepted: 03/18/2021] [Indexed: 10/21/2022]
27
Dugourd PM, Guillot P, Beylot-Barry M, Cogrel O. Surgical treatment of rhinophyma: Retrospective monocentric study and literature review. Ann Dermatol Venereol 2021;148:172-176. [PMID: 34176641 DOI: 10.1016/j.annder.2021.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2019] [Revised: 01/14/2021] [Accepted: 02/05/2021] [Indexed: 11/19/2022]
28
Beylot-Barry M, Seneschal J, Tran D, Bachelez H, Beneton N, Dupuy A, Joly P, Jullien D, Mahé E, Paul C, Richard MA, Sbidian E, Viguier M, Chosidow O, Tubach F. Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort. Br J Dermatol 2021;185:1052-1054. [PMID: 34128543 DOI: 10.1111/bjd.20585] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 06/13/2021] [Accepted: 06/13/2021] [Indexed: 01/20/2023]
29
Skayem C, Beylot-Barry M, de Masson A, Dereure O, Ram-Wolff C, Bagot M, Vergier B, Battistella M, Ortonne N, Ingen-Housz-Oro S. Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases. Br J Dermatol 2021;185:1061-1063. [PMID: 34128541 DOI: 10.1111/bjd.20580] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Revised: 06/08/2021] [Accepted: 06/13/2021] [Indexed: 12/01/2022]
30
costedoat I, Leroy-Colavolpe V, Dousset L, Beylot-Barry M, Doutre M. Cellulite de Wells à type d’œdème récidivant du visage : 3 cas. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
31
Bergqvist C, Beylot-Barry M, Ram-Wolff C, Vergier B, Bagot M, Battistella M, Dalle S, Balme B, Merlio JP, Durupt F, Le Corre Y, Bonnet N, Le Bozec P, Skowron F, Vivard-Wallee I, Dereure O, Brunet-Possenti F, Ingen-Housz-Oro S, Ortonne N. Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group. Clin Exp Dermatol 2021;46:1441-1451. [PMID: 33987864 DOI: 10.1111/ced.14730] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/10/2021] [Indexed: 11/30/2022]
32
Hacard F, Giraudeau B, d'Acremont G, Jegou MH, Jonville-Bera AP, Munck S, Pham BN, Mavoungou S, Cornillier H, Guillot B, Beylot-Barry M, Chosidow O, Maruani A. Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Br J Dermatol 2021;185:658-660. [PMID: 33913519 PMCID: PMC8457139 DOI: 10.1111/bjd.20415] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 04/19/2021] [Accepted: 04/23/2021] [Indexed: 11/30/2022]
33
Guelimi R, Salle R, Dousset L, Assier H, Fourati S, Bhujoo Z, Barbarot S, Boulard C, Cazanave C, Colin A, Kostrzewa E, Lesort C, Levy Roy A, Lombart F, Marco Bonnet J, Marty L, Monfort JB, Riffaud L, Samimi M, Tardieu M, Sbidian E, Wolkenstein P, Le Cleach L, Beylot-Barry M. Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology. J Eur Acad Dermatol Venereol 2021;35:e539-e541. [PMID: 33914975 PMCID: PMC8242387 DOI: 10.1111/jdv.17322] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 03/26/2021] [Accepted: 04/16/2021] [Indexed: 01/08/2023]
34
Hodak E, Sherman S, Papadavid E, Bagot M, Querfeld C, Quaglino P, Prince HM, Ortiz-Romero PL, Stadler R, Knobler R, Guenova E, Estrach T, Patsatsi A, Leshem YA, Prague-Naveh H, Berti E, Alberti-Violetti S, Cowan R, Jonak C, Nikolaou V, Mitteldorf C, Akilov O, Geskin L, Matin R, Beylot-Barry M, Vakeva L, Sanches JA, Servitje O, Weatherhead S, Wobser M, Yoo J, Bayne M, Bates A, Dunnill G, Marschalko M, Buschots AM, Wehkamp U, Evison F, Hong E, Amitay-Laish I, Stranzenbach R, Vermeer M, Willemze R, Kempf W, Cerroni L, Whittaker S, Kim YH, Scarisbrick JJ. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. Br J Dermatol 2021;184:524-531. [PMID: 32574377 DOI: 10.1111/bjd.19303] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/30/2020] [Indexed: 12/12/2022]
35
Beytout Q, Pepiot J, Maruani A, Devulder D, Aubert R, Beylot-Barry M, Amici JM, Jullien D, Mahé E. Impact of the COVID-19 pandemic on children with psoriasis. Ann Dermatol Venereol 2021;148:106-111. [PMID: 33637347 PMCID: PMC7901834 DOI: 10.1016/j.annder.2021.01.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 12/04/2020] [Accepted: 01/18/2021] [Indexed: 12/19/2022]
36
Bertolotti A, Sbidian E, Join-Lambert O, Bourgault-Villada I, Moyal-Barracco M, Perrot P, Jouan N, Yordanov Y, Sidorkiewicz S, Chazelas K, Bru-Daprés MF, Caumes E, Sei JF, Chosidow O, Beylot-Barry M. Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Br J Dermatol 2020;184:963-965. [PMID: 33278829 PMCID: PMC8247998 DOI: 10.1111/bjd.19710] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 12/02/2020] [Accepted: 12/02/2020] [Indexed: 11/28/2022]
37
Maubec E, Boubaya M, Petrow P, Beylot-Barry M, Basset-Seguin N, Deschamps L, Grob J, Dréno B, Scheer-Senyarich I, Bloch-Queyrat C, Leccia MT, Stefan A, Saiag P, Grange F, Meyer N, de Quatrebarbes J, Dinulescu M, Legoupil D, Machet L, Dereure O, Zehou O, Montaudié H, Wierzbicka-Hainaut E, Le Corre Y, Mansard S, Guegan S, Arnault JP, Dalac S, Aubin F, Alloux C, Lopez I, Cherbal S, Tibi A, Dalac S, Levy V. Étude de phase II de l’administration de pembrolizumab (MK-3475) en monothérapie et en première ligne chez des patients présentant un carcinome épidermoïde cutané non opérable. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
38
Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L, Cazanave C, Colin A, Kostrzewa E, Lesort C, Levy Roy A, Lombart F, Marco-Bonnet J, Monfort J, Samimi M, Tardieu M, Wolkenstein P, Sbidian E, Beylot-Barry M. La majorité des engelures observées durant l’épidémie de COVID-19 ne semblent pas dues à l’infection par le SRAS-Cov-2. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
39
Ducharme O, Pouchot J, Amico S, Milpied B, Seneschal J, Beylot-Barry M, Pham-Ledard A. Omalizumab : une nouvelle option thérapeutique pour la pemphigoïde bulleuse. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
40
Menguy S, Mansour Y, Augereau O, Ortonne N, Balme B, Battistella M, Lamant L, Beltzung F, Szablewski V, Gaulard P, Bagot M, Beylot-Barry M, Vergier B. Impact des algorithmes du Groupe Français d’Étude des Lymphomes Cutanés sur le diagnostic anatomopathologique des lymphoproliférations cutanées. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
41
Toulemonde E, Marabelle A, Fléchon A, Chevret S, Simon C, Beylot-Barry M, Mortier L. AcSé Nivolumab : résultats préliminaires pour le carcinome trichoblastique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
42
Pacaud A, Dousset L, Dorizy-Duong V, Gérard E, Beylot-Barry M, Pham-Ledard A. Infiltration granulomateuse alopéciante du cuir chevelu sous mogamulizumab : 2 cas. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
43
Beytout Q, Pepiot J, Maruani A, Devulder D, Aubert R, Beylot-Barry M, Amici JM, Jullien D, Mahé E. Impact de l’épidémie de Covid-19 sur le psoriasis de l’enfant en France. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
44
Valentin J, Gérard E, Dousset L, Prey S, Dutriaux C, Beylot-Barry M, Pham-Ledard A. Tolérance du cémiplimab en vie réelle : étude rétrospective monocentrique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
45
Villani A, Amatore F, Tauber M, Guillot B, Viguier M, Beylot-Barry M, Jullien D. Impact des recommandations françaises sur les habitudes de prescription des traitements systémiques pour le psoriasis modéré à sévère. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
46
Khammari A, Dinulescu M, Nguyen JM, Cassecuel J, Maillard H, Le Duff F, Machet L, Beylot-Barry M, Legoupil D, Wierzbicka-Hainaut E, Bedane C, Leccia MT, Debarbieux S, Meyer N, Monestier S, Bens G, Denis M, Vourch M, Bossard C, Vergier B, Dréno B. L’efficacité de l’imiquimod dans la prise en charge du mélanome de Dubreuilh in situ (lentigo malin). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
47
Guicheney M, Pham-Ledard A, Beylot-Barry M, Dousset L, Prey S, Dutriaux C, Gerard E, Dequidt L. Encorafénib-binimétinib : des résultats encourageants notamment en intracrânien. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
48
Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Oro S, Battistella M, d’Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereur O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M. Changements dans l’épidémiologie des lymphomes cutanés primitifs en France : une analyse de 8593 patients du registre du Groupe Français d’Etude des Lymphomes Cutanés (GFELC). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
49
Condamina M, Tran VT, Penso L, Hotz C, Guillem P, Villani A, Perrot P, Bru MF, Jacquet E, Nassif A, Bachelez H, Wolkenstein P, Beylot-Barry M, Richard MA, Ravaud P, Viguier M, Sbidian E. Caractéristiques cliniques des patients atteints d’hidradénite suppurée participants à la e-cohorte ComPaRe et comparaison avec les données de la littérature. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
50
Merhi R, Ducharme O, Pham-Ledard A, Beylot-Barry M, Gérard E. Évolution fatale d’un syndrome de lyse tumorale sous double immunothérapie (anti-CTLA-4 et anti-PD1). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
PrevPage 2 of 16 123451516Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA